Free Trial

Natalya Davies Analyst Performance

Analyst at Roth Mkm

Natalya Davies is a stock analyst at Roth Mkm focused in the medical sector, covering 4 publicly traded companies. Over the past year, Natalya Davies has issued 5 stock ratings, including and buy recommendations. While full access to Natalya Davies' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Natalya Davies' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
5 Last 0 Years
Buy Recommendations
100.00% 4 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%4 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
50.0% of companies on NASDAQ
2 companies
NYSE
50.0% of companies on NYSE
2 companies

Natalya Davies, an analyst at Roth Mkm, currently covers 4 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
3 companies
75.0%
Computer and Technology
1 company
25.0%

Natalya Davies of Roth Mkm specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
1 company
25.0%
INSTRU - SCIENTFC
1 company
25.0%
MED INSTRUMENTS
1 company
25.0%
MED PRODUCTS
1 company
25.0%

Natalya Davies' Ratings History at Roth Mkm

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Repligen Corporation stock logo
RGEN
Repligen
4/17/2026Initiated Coverage$133.25$160.00Buy
Bruker Corporation stock logo
BRKR
Bruker
11/20/2025Initiated Coverage$43.39$60.00Buy
Waters Corporation stock logo
WAT
Waters
10/8/2025Set Price Target$318.64$390.00
Waters Corporation stock logo
WAT
Waters
10/8/2025Initiated Coverage$318.64$390.00Buy
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
10/8/2025Initiated Coverage$138.56$165.00Buy